{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:04:57Z","timestamp":1783004697932,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jjcc.2023.01.003","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T02:33:02Z","timestamp":1674181982000},"page":"553-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome"],"prefix":"10.1016","volume":"81","author":[{"given":"Hirokazu","family":"Shimono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Tokushige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Fukuyado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsumasa","family":"Akao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Kawasoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Arikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Otsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Chaen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Okui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Oketani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2023.01.003_bb0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Mortality and causes of death collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0010","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jacc.2006.06.050","article-title":"Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials","volume":"48","author":"Bavry","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0015","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(16)31276-4","article-title":"Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study","volume":"388","author":"Wallentin","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0025","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2007.02.027","article-title":"Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial","volume":"49","author":"Manoukian","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0030","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jacc.2015.06.1323","article-title":"Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention","volume":"66","author":"G\u00e9n\u00e9reux","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0035","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005542","article-title":"Bleeding severity after percutaneous coronary intervention","volume":"11","author":"Redfors","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0045","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2019.8145","article-title":"Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial","volume":"321","author":"Watanabe","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0050","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the academic research consortium for high bleeding risk","volume":"40","author":"Urban","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0055","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.jacc.2020.03.070","article-title":"Validation of the academic research consortium high bleeding risk definition in contemporary PCI patients","volume":"75","author":"Cao","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0060","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.4244\/EIJ-D-20-00345","article-title":"High bleeding risk and clinical outcomes in east asian patients undergoing percutaneous coronary intervention: the PENDULUM registry","volume":"16","author":"Nakamura","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.amjcard.2008.02.088","article-title":"Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention","volume":"102","author":"Lev","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.recesp.2011.10.019","article-title":"Comparison of the prognostic predictive value of the TIMI, PAMI, CADILLAC, and GRACE risk scores in STEACS undergoing primary or rescue PCI","volume":"65","author":"M\u00e9ndez-Eir\u00edn","year":"2012","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0075","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1253\/circj.CJ-19-0133","article-title":"JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome","volume":"83","author":"Kimura","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0080","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4244\/EIJ-D-20-00052","article-title":"Validation of the academic research consortium for high bleeding risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores","volume":"16","author":"Ueki","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0085","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jacc.2005.01.041","article-title":"Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the Cadillac risk score","volume":"45","author":"Halkin","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0090","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/eurheartj\/ehz898","article-title":"Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome","volume":"41","author":"Haider","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0095","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.amjcard.2017.03.016","article-title":"Comparison of outcomes and prognosis of patients with versus without newly diagnosed diabetes mellitus after primary percutaneous coronary intervention for ST-elevation myocardial infarction (the HORIZONS-AMI Study)","volume":"119","author":"Ertelt","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijcard.2018.07.137","article-title":"Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction","volume":"272","author":"Hall","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0105","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jacc.2016.05.049","article-title":"Predicting in-hospital mortality in patients with acute myocardial infarction","volume":"68","author":"McNamara","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0110","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/eurheartj\/ehm184","article-title":"Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction","volume":"28","author":"Sorajja","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0115","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.jacc.2019.03.531","article-title":"From early pharmacology to recent pharmacology interventions in acute coronary syndromes: JACC state-of-the-art review","volume":"74","author":"Szummer","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0120","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1253\/circj.CJ-19-1109","article-title":"JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease","volume":"84","author":"Nakamura","year":"2020","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0125","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008307","article-title":"Application of the academic research consortium high bleeding risk criteria in an all-comers registry of percutaneous coronary intervention","volume":"12","author":"Natsuaki","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0130","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1253\/circj.CJ-21-0016","article-title":"Effects of acute coronary syndrome and stable coronary artery disease on bleeding and ischemic risk after percutaneous coronary intervention","volume":"85","author":"Natsuaki","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0135","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1253\/circj.CJ-19-1117","article-title":"Transradial vs. Transfemoral percutaneous coronary intervention in patients with or without high bleeding risk criteria","volume":"84","author":"Yamamoto","year":"2020","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0140","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1253\/circj.CJ-20-0836","article-title":"Application of the modified high bleeding risk criteria for japanese patients in an all-comers registry of percutaneous coronary intervention \u2014 from the CREDO-Kyoto registry Cohort-3 \u2014","volume":"85","author":"Natsuaki","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0145","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1253\/circj.CJ-21-0120","article-title":"Academic research consortium for high bleeding risk definitions for early, late, and very late bleeding events","volume":"85","author":"Miura","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jjcc.2021.04.005","article-title":"Impact of Cadillac and GRACE risk scores on short- and long-term clinical outcomes in patients with acute myocardial infarction","volume":"78","author":"Sato","year":"2021","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0155","first-page":"804","article-title":"Trade-off of myocardial infarction vs. Bleeding types on mortality after acute coronary syndrome: lessons from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRACER) randomized trial","volume":"38","author":"Valgimigli","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0160","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1001\/jama.2020.7580","article-title":"Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical trial","volume":"323","author":"Kim","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2023.01.003_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12928-021-00829-9","article-title":"CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022","volume":"37","author":"Ozaki","year":"2022","journal-title":"Cardiovasc Interv Ther"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508723000035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508723000035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:07:44Z","timestamp":1760274464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508723000035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0914508723000035"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2023.01.003","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2023.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}